Richard L. Lindstrom Md.

Director, TLC VISION CORP.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jun 10, 2026Granted 14,000 shares of OCULAR THERAPEUTIX, INC⁵
Jun 3, 2026Granted 17,421 shares of LENSAR, Inc.⁶
Feb 20, 2026Bought 60,229 shares at $7.66 of OCULAR THERAPEUTIX, INC⁷
Jun 11, 2025Granted 14,000 shares of OCULAR THERAPEUTIX, INC⁸
May 23, 2025Granted 7,374 shares of LENSAR, Inc.⁹
May 8, 2025Bought 10,000 shares at $6.96 of OCULAR THERAPEUTIX, INC¹⁰
Jul 24, 2024Granted 12,000 shares of OCULAR THERAPEUTIX, INC¹¹
May 7, 2024Granted 22,000 shares of LENSAR, Inc.¹²
Feb 27, 2024Exercised options 11,363 shares at $8.80 of OCULAR THERAPEUTIX, INC¹¹
Feb 27, 2024Exercised options 18,939 shares at $8.80 of OCULAR THERAPEUTIX, INC¹¹
Jun 14, 2023Granted 12,000 shares of OCULAR THERAPEUTIX, INC¹³
May 25, 2023Granted 9,288 shares of LENSAR, Inc.¹⁴
Sep 30, 2022Sold 40,000 shares at $12.62 of Harrow Health⁴
Jun 16, 2022Granted 8,933 shares of OCULAR THERAPEUTIX, INC¹⁵
May 25, 2022Granted 4,285 shares of LENSAR, Inc.¹⁶
May 12, 2022Exercised options 9,469 shares at $1.22 of OCULAR THERAPEUTIX, INC¹⁷

The numbers on this page point here. Each one links to the record it came from.